Masimo wants ITC to block Apple watches
DenPhotos / Shutterstock.com
With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
In what turns out to be a multifaceted dispute against Masimo Corporation, the tech giant has lost in the most recent case—a patent clash which could, at worst, result in an import ban of the offending products in the US.
Apple, through the importation, sale and distribution of its smartwatches that feature light-based pulse oximetry functionality and components, has been found to have violated Section 337 of the Tariff Act, according to an Administrative Law Judge (ALJ) in Washington last week (January 10).
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
patents, technology, Apple, Masimo, AliveCor, US